Royalty Pharma plc - Class A (RPRX) Company Profile & Statistics

Royalty Pharma plc - Class A
RPRX
(Nasdaq - US)
Closed
26.39
+0.17 (+0.65%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
26.30
High
26.66
Low
26.30

About Royalty Pharma plc - Class A

CEO

Pablo Legorreta

Headquarters

110 east 59th street

new york, ny 10022, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.royaltypharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.

Royalty Pharma plc - Class A Statistics

Valuation Measures

Market Capitalization ²	15.14B
Enterprise Value	21.80B
Enterprise Value/EBITDA (ttm)	13.95
Price to Earnings Ratio (ttm)	6.30
Price to Book (mrq)	1.50
Price to Sales (ttm)	6.76
Price to Cash (ytd)	5.70

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	108.65%
Profit Margin (ttm)	49.77%
Return on Equity (ttm)	24.65%
Return on Invested Capital (ttm)	10.30%
Return on Assets (ttm)	14.44%

Income Statement

Revenue (ttm)	2.27B
Revenue Per Share (ttm)	3.85
Gross Profit (ttm)	2.27B
EBITDA (ttm)³	1.56B
Net Income Avi to Common (ttm)	1.15B
Diluted EPS (ttm)	1.93

Share Statistics

Beta (5Y Monthly)	0.47
52-Week Change	1.04%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	589.18M
Dividend Yield	3.23%
Float ⁴	477.83M
% Held by Insiders	18.90%
% Held by Institutions	54.35%

Balance Sheet

Total Cash (mrq)	998.55M
Total Cash Per Share (mrq)	1.69
Total Debt (mrq)	7.61B
Total Debt/Equity (mrq)	74.16%
Current Ratio (mrq)	1.54%
Quick Ratio (mrq)	1.54%
Book Value Per Share (mrq)	10.45

Cash Flow

Operating Cash Flow Per Share (ytd)	3.42
Free Cash Flow (ytd)	17.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Royalty Pharma plc - Class A

Trade With A Regulated Broker